Circulating tumor cells: evolving evidence and future challenges.

Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that originate from the primary tumor or metastatic sites. New techniques have been developed to isolate and characterize these cells. CTC enumeration has been incorporated into different fields of oncology as a prognostic marker, a tool to monitor therapy response, and a method to understand basic tumor characteristics. This review covers the different techniques available for isolation of CTCs, the clinical utility of CTCs in breast, prostate, and colon cancer, and future directions in this field.

[1]  P. Steeg Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[2]  U. Metzger,et al.  Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer , 2002, Annals of surgery.

[3]  Robert Rosenberg,et al.  Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[4]  Mehmet Toner,et al.  The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  T. Aoki,et al.  Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR , 2006, International Journal of Clinical Oncology.

[6]  M. Noble,et al.  Cancer stem cells. , 2006, The New England journal of medicine.

[7]  S Miltenyi,et al.  Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. , 1998, Experimental hematology.

[8]  H. Scher,et al.  Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[9]  G. T. Budd,et al.  Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.

[10]  M. Dowsett,et al.  Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques , 2005, British Journal of Cancer.

[11]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[12]  R. Butler,et al.  Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. , 1993, Cancer research.

[13]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[14]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[15]  A. Adjei,et al.  Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor , 2007, Clinical Cancer Research.

[16]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[17]  D. Mavroudis,et al.  Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Uhr,et al.  Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. , 2002, International journal of oncology.

[19]  L. Weiner,et al.  Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. , 2006, Clinical colorectal cancer.

[20]  W. J. Allard,et al.  Circulating tumor cells predict survival in patients with metastatic prostate cancer. , 2005, Urology.

[21]  L. Fink,et al.  Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors , 2009, Cancer Epidemiology Biomarkers & Prevention.

[22]  G. Kallergi,et al.  Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer , 2008, Clinical Cancer Research.

[23]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[24]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[25]  Li Zhang,et al.  Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  Stefan Sleijfer,et al.  Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.

[27]  D. Dearnaley,et al.  Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  U. Metzger,et al.  Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer , 2003, The British journal of surgery.

[29]  T. Fehm,et al.  Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status , 2007, Breast Cancer Research.

[30]  Annibale Biggeri,et al.  Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients , 2009, Breast Cancer Research and Treatment.

[31]  Y. Takagi,et al.  Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. , 2000, Annals of surgery.

[32]  C. Sotiriou,et al.  Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  W. Grody,et al.  The Clinical Significance of Circulating Tumor Cells in the Peripheral Blood , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[34]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[35]  P. Paterlini-Bréchot,et al.  Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.

[36]  D. Hayes,et al.  The measurement and therapeutic implications of circulating tumour cells in breast cancer , 2005, British Journal of Cancer.

[37]  A. Lacy,et al.  Prognostic Value of Postoperative Detection of Blood Circulating Tumor Cells in Patients With Colorectal Cancer Operated on For Cure , 2003, Annals of surgery.

[38]  Glenn Heller,et al.  Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[39]  E. Slodkowska,et al.  Circulating and disseminated tumor cells in the management of breast cancer. , 2009, American journal of clinical pathology.

[40]  S. Rodenhuis,et al.  Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells , 1999, Breast Cancer Research and Treatment.

[41]  Alessandro Ambrosi,et al.  The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis , 2006, Clinical Cancer Research.

[42]  S. Yasuda,et al.  Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase‐polymerase chain reaction , 2001, Cancer.

[43]  Michael L Pearl,et al.  Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. , 2009, Gynecologic oncology.

[44]  Peter Kuhn,et al.  High speed detection of circulating tumor cells. , 2006, Biosensors & bioelectronics.

[45]  Tanja Fehm,et al.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.

[46]  Xiaoyu Jia,et al.  Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. , 2009, The Lancet. Oncology.

[47]  R. Coombes,et al.  Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  J. Nesland,et al.  Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. , 2004, Cytotherapy.

[49]  R. Babaian,et al.  Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. , 2008, The Journal of urology.

[50]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[52]  F. Orr,et al.  Cancer cell interactions with injured or activated endothelium , 1992, Cancer and Metastasis Reviews.

[53]  F. Itokawa,et al.  Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. , 2008, Journal of hepato-biliary-pancreatic surgery.

[54]  M. Naoe,et al.  Detection of circulating urothelial cancer cells in the blood using the CellSearch System , 2007, Cancer.

[55]  J. Goeminne,et al.  Pitfalls in the detection of disseminated non-hematological tumor cells. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  Kristine Broglio,et al.  Circulating tumor cells in metastatic breast cancer , 2008, Cancer.

[57]  C. Glover,et al.  Clearance of Circulating Tumor Cells After Excision of Primary Colorectal Cancer , 2002, Annals of surgery.

[58]  C. Punt,et al.  Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  M. Rubin,et al.  Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase‐polymerase chain reaction assay in patients with early stage prostate carcinoma , 1997, Cancer.

[60]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[61]  K. Pienta,et al.  Global gene expression profiling of circulating tumor cells. , 2005, Cancer research.

[62]  U. Demel,et al.  Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. , 2004, Journal of experimental & clinical cancer research : CR.

[63]  L. Tanoue,et al.  Detection of Mutations in EGFR in Circulating Lung-Cancer Cells , 2010 .

[64]  O. Böcher,et al.  The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. , 2007, Anticancer research.

[65]  Dieter Lutz,et al.  Tumor cell detection in peripheral blood and bone marrow , 2006, Current opinion in oncology.

[66]  Hellmut Samonigg,et al.  Comparison of two methods for enumerating circulating tumor cells in carcinoma patients , 2005, Cytometry. Part B, Clinical cytometry.

[67]  C. Glover,et al.  Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma , 2007, The British journal of surgery.

[68]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Oscar Lin,et al.  Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer , 2009, Clinical Cancer Research.

[70]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  Tanja Fehm,et al.  HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Evan T Keller,et al.  Detection and isolation of circulating tumor cells in urologic cancers: a review. , 2004, Neoplasia.

[73]  A. Choy,et al.  Detection and enumeration of circulating tumour cells in colorectal cancer , 1993, The British journal of surgery.

[74]  N. Kaibara,et al.  Prognostic significance of reverse transcriptase‐polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma , 2000, Cancer.

[75]  W. Gerald,et al.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.